Steven Lichtman
Stock Analyst at William Blair
(4.73)
# 666
Out of 4,382 analysts
989
Total ratings
51.7%
Success rate
13.1%
Average return
Main Sectors:
Stocks Rated by Steven Lichtman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Maintained: Buy | n/a | $67.34 | - | 30 | Jun 5, 2026 | |
| PODD Insulet | Maintained: Buy | n/a | $153.22 | - | 64 | Jun 4, 2026 | |
| GKOS Glaukos | Maintained: Buy | n/a | $125.00 | - | 14 | Jun 3, 2026 | |
| DXCM DexCom | Maintained: Buy | n/a | $72.86 | - | 89 | May 15, 2026 | |
| ENOV Enovis | Maintained: Buy | n/a | $23.78 | - | 2 | May 8, 2026 | |
| RXST RxSight | Maintained: Hold | n/a | $5.00 | - | 15 | May 8, 2026 | |
| SGHT Sight Sciences | Reiterated: Buy | n/a | $4.46 | - | 3 | May 7, 2026 | |
| SWX: ALC Alcon Inc. | Maintained: Hold | n/a | $53.08 | - | 7 | May 6, 2026 | |
| SYK Stryker | Reiterated: Buy | n/a | $305.66 | - | 52 | May 1, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintained: Hold | n/a | $87.33 | - | 72 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $14 | $14.23 | -1.62% | 1 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $15 | $3.40 | +341.18% | 22 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $118 | $48.55 | +143.05% | 81 | Aug 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $7.5 | $13.89 | n/a | 22 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $73 → $78 | $80.00 | n/a | 69 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $87 → $116 | $64.48 | n/a | 14 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $16 | $11.94 | n/a | 6 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $275 | $320.53 | n/a | 1 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $29.99 | n/a | 5 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $92 → $94 | $81.67 | n/a | 146 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 | $19.34 | n/a | 43 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $16.99 | n/a | 123 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.5 | $4.64 | n/a | 3 | Sep 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 17 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.42 | n/a | 15 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.27 | n/a | 8 | Dec 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.01 | n/a | 13 | Dec 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $237 | $289.48 | n/a | 1 | Feb 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.5188 | n/a | 11 | May 27, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.1672 | n/a | 26 | Mar 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.88 | n/a | 13 | Mar 13, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.78 | n/a | 1 | Oct 7, 2011 |
The Cooper Companies
Jun 5, 2026
Maintained: Buy
Price Target: n/a
Current: $67.34
Upside: -
Insulet
Jun 4, 2026
Maintained: Buy
Price Target: n/a
Current: $153.22
Upside: -
Glaukos
Jun 3, 2026
Maintained: Buy
Price Target: n/a
Current: $125.00
Upside: -
DexCom
May 15, 2026
Maintained: Buy
Price Target: n/a
Current: $72.86
Upside: -
Enovis
May 8, 2026
Maintained: Buy
Price Target: n/a
Current: $23.78
Upside: -
RxSight
May 8, 2026
Maintained: Hold
Price Target: n/a
Current: $5.00
Upside: -
Sight Sciences
May 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.46
Upside: -
Alcon Inc.
May 6, 2026
Maintained: Hold
Price Target: n/a
Current: $53.08
Upside: -
Stryker
May 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $305.66
Upside: -
Zimmer Biomet Holdings
Apr 29, 2026
Maintained: Hold
Price Target: n/a
Current: $87.33
Upside: -
Mar 31, 2026
Initiated Coverage: Buy
Price Target: $14
Current: $14.23
Upside: -1.62%
Sep 5, 2025
Maintained: Buy
Price Target: $12 → $15
Current: $3.40
Upside: +341.18%
Aug 3, 2025
Maintained: Hold
Price Target: $118
Current: $48.55
Upside: +143.05%
May 14, 2025
Maintained: Buy
Price Target: $11 → $7.5
Current: $13.89
Upside: n/a
May 9, 2025
Maintained: Hold
Price Target: $73 → $78
Current: $80.00
Upside: n/a
Feb 26, 2025
Maintained: Buy
Price Target: $87 → $116
Current: $64.48
Upside: n/a
Jan 10, 2025
Maintained: Buy
Price Target: $13 → $16
Current: $11.94
Upside: n/a
Dec 16, 2024
Initiated Coverage: Buy
Price Target: $275
Current: $320.53
Upside: n/a
Nov 1, 2024
Maintained: Hold
Price Target: n/a
Current: $29.99
Upside: n/a
Aug 21, 2024
Maintained: Hold
Price Target: $92 → $94
Current: $81.67
Upside: n/a
Aug 2, 2024
Maintained: Buy
Price Target: $58
Current: $19.34
Upside: n/a
May 7, 2024
Downgraded: Hold
Price Target: n/a
Current: $16.99
Upside: n/a
Sep 19, 2023
Maintained: Buy
Price Target: $3.5
Current: $4.64
Upside: n/a
Feb 6, 2023
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Aug 10, 2022
Downgraded: Hold
Price Target: n/a
Current: $2.42
Upside: n/a
Dec 31, 2020
Rated: Hold
Price Target: n/a
Current: $1.27
Upside: n/a
Dec 18, 2018
Rated: Hold
Price Target: n/a
Current: $7.01
Upside: n/a
Feb 8, 2018
Reiterated: Buy
Price Target: $237
Current: $289.48
Upside: n/a
May 27, 2016
Reiterated: Hold
Price Target: n/a
Current: $0.5188
Upside: n/a
Mar 4, 2016
Downgraded: Hold
Price Target: n/a
Current: $0.1672
Upside: n/a
Mar 13, 2015
Downgraded: Hold
Price Target: n/a
Current: $0.88
Upside: n/a
Oct 7, 2011
Downgraded: Hold
Price Target: n/a
Current: $1.78
Upside: n/a